glp-1 and diabetes Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Glucagon-Like Peptide-1: New Regulator in

If you experience significant nausea or other GI problems at a new dose, you have two options

Taking these medications with Wegovy can increase the risk of hypoglycemia

Still in trials: Retatrutide is not yet FDA-approved

It is often well-tolerated in moderate doses but may have a mild laxative effect, which could be problematic for GLP-1 users already experiencing diarrhea or gastrointestinal upset

GoodRx or Costco cash pricing (as low as $149 to $349 depending on pharmacy and dose)

Compounding pharmacies became a major source of GLP-1 medicines as patients struggled to access or afford branded products from Novo Nordisk and Eli Lilly in the early stages of the drugs launches